The primary objective of this study is to evaluate the pharmacokinetic profile of vonoprazan
in adolescent participants with symptomatic gastroesophageal reflux disease (GERD).
This clinical trial information was submitted voluntarily under the applicable law and,
therefore, certain submission deadlines may not apply. (That is, clinical trial information
for this applicable clinical trial was submitted under section 402(j)(4)(A) of the Public
Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by
sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.).
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.